Beyond the drug knowledge business: why we’re here.
Take a moment to consider the real impact of advances in medication decision support. Clinicians better able to manage increasing therapeutic complexity. Healthcare organizations finding new ways to operate more efficiently and effectively. A world triumphing over the dangers of medication errors. And, most important, millions of lives sustained and enhanced as a result.
If you ask us what it's like to do business with FDB, we'll gladly describe our corporate objectives, highly inventive and responsive staff, methods of operation, programs and policies, and, of course, the value we offer our customers.
But if you want to know why we're in business in the first place, you'll have to look deeper. What you'll find is an unshakeable commitment to the difference-making power of drug knowledge. Coupled with an unrelenting determination to help leverage medication intelligence and insights to improve human health.
First Databank (FDB), a subsidiary of Hearst, provides drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions.
We offer more than three decades of experience in helping transform drug knowledge into comprehensive, actionable, targeted, and intuitive solutions that improve patient safety and healthcare outcomes.
Our network. Vital information.
FDB is part of the Hearst Health network, which also includes Zynx Health and MCG. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey.